切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - P-glycoprotein (P-gp) - Inward Rectifier Potassium (Kir) Channels - Dihydroorotate dehydrogenase - Liver X receptors (LXRs)

17件产品中的 1-10

页面
每页
清除全部
  1. SR-9243
    A8714 SR-9243
    Target: Liver X receptors (LXRs)
    Summary: LXR反相激动剂
      ≥25.2 mg/mL
      insoluble in H2O
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Teriflunomide
    B1850 Teriflunomide
    中文名: 特立氟胺
    Target: Dihydroorotate dehydrogenase
    Summary: 二氢乳清酸脱氢酶的抑制剂
      ≥13.5 mg/mL
      insoluble in H2O
  6. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  7. LXR-623
    B1264 LXR-623
     2 Citation
    Target: Liver X receptors (LXRs)
    Summary: 肝X受体激动剂
      ≥19.4 mg/mL
      insoluble in H2O
  8. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    中文名: 唑喹达三盐酸盐
    Target: P-glycoprotein (P-gp)
    Summary: Pgb(P糖蛋白)抑制剂
      ≥17.1 mg/mL
      ≥31.9 mg/mL
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. T0901317
    A2249 T0901317
    Target: Liver X receptors (LXRs)
    Summary: 肝X受体激动剂
      ≥24.05 mg/mL
      insoluble in H2O

17件产品中的 1-10

页面
每页